Dual mechanism of modulation of NaV1.8 sodium channels by ouabain.

Canadian Journal of Physiology and Pharmacology
Vera B PlakhovaBoris V Krylov

Abstract

In the primary sensory neuron, ouabain activates the dual mechanism that modulates the functional activity of NaV1.8 channels. Ouabain at endogenous concentrations (EO) triggers two different signaling cascades, in which the Na,K-ATPase/Src complex is the EO target and the signal transducer. The fast EO effect is based on modulation of the NaV1.8 channel activation gating device. EO triggers the tangential signaling cascade along the neuron membrane from Na,K-ATPase to the NaV1.8 channel. It evokes a decrease in effective charge transfer of the NaV1.8 channel activation gating device. Intracellular application of PP2, an inhibitor of Src kinase, completely eliminated the effect of EO, thus indicating the absence of direct EO binding to the NaV1.8 channel. The delayed EO effect probably controls the density of NaV1.8 channels in the neuron membrane. EO triggers the downstream signaling cascade to the neuron genome, which should result in a delayed decrease in the NaV1.8 channels' density. PKC and p38 MAPK are involved in this pathway. Identification of the dual mechanism of the strong EO effect on NaV1.8 channels makes it possible to suggest that application of EO to the primary sensory neuron membrane should result in a potent ...Continue Reading

References

May 10, 1976·Experimental Brain Research·T JärvilehtoP Laurinen
Jan 1, 1992·Progress in Neurobiology·R D TreedeJ N Campbell
Sep 4, 1987·Science·R Levi-Montalcini
Jan 1, 1987·Physiological Reviews·J M Besson, A Chaouch
Jul 1, 1968·Physiological Reviews·R Levi-Montalcini, P U Angeletti
Oct 1, 1970·Acta Physiologica Scandinavica·M Knibestöl, A B Vallbo
Jul 1, 1968·Experimental Neurology·A B Vallbo, K E Hagbarth
Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
Sep 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·A A TymiakE Haber
Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·M S GoldJ D Levine
Nov 1, 1996·Neuroscience·H L Read, R M Siegel
Jan 1, 1996·Progress in Brain Research·W D WillisK N Westlund
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·A KawamuraK Nakanishi
Jul 8, 1999·Proceedings of the National Academy of Sciences of the United States of America·M S Gold
Sep 12, 2000·Neuroscience and Behavioral Physiology·B V KrylovN L Izvarina
Apr 28, 1955·The Journal of Physiology·A L HODGKIN, R D KEYNES
Apr 1, 1952·The Journal of Physiology·A L HODGKIN, A F HUXLEY
Apr 1, 1952·The Journal of Physiology·A L HODGKIN, A F HUXLEY
Apr 1, 1952·The Journal of Physiology·A L HODGKIN, A F HUXLEY
Jun 29, 2004·The Journal of Pain : Official Journal of the American Pain Society·Harry J GouldDennis Paul
Jan 22, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tracy D Wilson-GerwingValerie M K Verge
Jun 23, 2005·Frontiers in Bioscience : a Journal and Virtual Library·Maxim Dobretsov, Joseph R Stimers
Jun 15, 2007·Journal of the Peripheral Nervous System : JPNS·Weiran ChenAhmet Höke
Aug 22, 2007·Micron : the International Research and Review Journal for Microscopy·Tatyana G KuznetsovaRenat I Zhdanov
Mar 21, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Andy HudmonSulayman D Dib-Hajj
Jul 8, 2008·Experimental Neurology·Tracy D Wilson-GerwingValerie M K Verge
Jan 12, 2010·Nature Genetics·John C ChambersJaspal S Kooner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.